Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1994 Sep;38(3):205–212. doi: 10.1111/j.1365-2125.1994.tb04343.x

The pharmacokinetics and pharmacodynamics of quinine in the diabetic and non-diabetic elderly.

J R Dyer 1, T M Davis 1, C Giele 1, T Annus 1, P Garcia-Webb 1, J Robson 1
PMCID: PMC1364791  PMID: 7826821

Abstract

1. Quinine is a front-line antimalarial drug but is prescribed most commonly in nonmalarious countries for cramps. Postural hypotension, hearing loss and hyperinsulinaemic hypoglycaemia occur in malaria and overdose but little is known of quinine kinetics and toxicity in the elderly. 2. We studied 12 non-insulin-dependent diabetics and 10 non-diabetic controls aged 51-79 years. Subjects attended on two occasions > 7 days apart. On each test day, subjects were given a 600 Cal meal at 18.00 h (0 h) and, on one occasion, quinine sulphate 600 mg at 22.00 h (4 h). Venous blood samples for glucose, insulin and quinine assay were drawn pre-prandially and then regularly over the next 38 h. Supine and erect blood pressures were taken and audiometry was performed at 4, 6, 8 and 14 h. A one-compartment open pharmacokinetic model was fitted to serum quinine concentrations. 3. Absorption and elimination half-times, volume of distribution and oral clearance of quinine were comparable in the two groups (P > 0.2) and there was a mean absorption lag-time of approximately 1 h. Basal and immediate post-prandial (< 4 h) serum glucose and insulin concentrations on both test days were similar in the diabetics and also in the non-diabetics, but quinine produced a mean reduction in serum glucose of 1.0 mmol l-1 from 3-5 h post-dose in both groups without affecting serum insulin concentrations. Quinine administration did not alter postural blood pressure changes or produce significant hearing loss in either group.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berlin C. M., Stackman J. M., Vesell E. S. Quinine-induced alterations in drug disposition. Clin Pharmacol Ther. 1975 Dec;18(6):670–679. doi: 10.1002/cpt1975186670. [DOI] [PubMed] [Google Scholar]
  2. Connolly P. S., Shirley E. A., Wasson J. H., Nierenberg D. W. Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Arch Intern Med. 1992 Sep;152(9):1877–1880. [PubMed] [Google Scholar]
  3. Davis T. M., Karbwang J., Looareesuwan S., Turner R. C., White N. J. Comparative effects of quinine and quinidine on glucose metabolism in healthy volunteers. Br J Clin Pharmacol. 1990 Sep;30(3):397–403. doi: 10.1111/j.1365-2125.1990.tb03790.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davis T. M., Pukrittayakamee S., Supanaranond W., Looareesuwan S., Krishna S., Nagachinta B., Turner R. C., White N. J. Glucose metabolism in quinine-treated patients with uncomplicated falciparum malaria. Clin Endocrinol (Oxf) 1990 Dec;33(6):739–749. doi: 10.1111/j.1365-2265.1990.tb03911.x. [DOI] [PubMed] [Google Scholar]
  5. Davis T. M., White N. J., Looareesuwan S., Silamut K., Warrell D. A. Quinine pharmacokinetics in cerebral malaria: predicted plasma concentrations after rapid intravenous loading using a two-compartment model. Trans R Soc Trop Med Hyg. 1988;82(4):542–547. doi: 10.1016/0035-9203(88)90498-1. [DOI] [PubMed] [Google Scholar]
  6. Hadjokas N., Goodfriend T. Inhibition of aldosterone production and angiotensin action by drugs affecting potassium channels. Pharmacology. 1991;43(3):141–150. doi: 10.1159/000138839. [DOI] [PubMed] [Google Scholar]
  7. Hall A. P., Czerwinski A. W., Madonia E. C., Evensen K. L. Human plasma and urine quinine levels following tablets, capsules, and intravenous infusion. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):580–585. doi: 10.1002/cpt1973144part1580. [DOI] [PubMed] [Google Scholar]
  8. Henquin J. C., Horemans B., Nenquin M., Verniers J., Lambert A. E. Quinine-induced modifications of insulin release and glucose metabolism by isolated pancreatic islets. FEBS Lett. 1975 Oct 1;57(3):280–284. doi: 10.1016/0014-5793(75)80317-6. [DOI] [PubMed] [Google Scholar]
  9. Jaeger A., Sauder P., Kopferschmitt J., Flesch F. Clinical features and management of poisoning due to antimalarial drugs. Med Toxicol Adverse Drug Exp. 1987 Jul-Aug;2(4):242–273. doi: 10.1007/BF03259868. [DOI] [PubMed] [Google Scholar]
  10. James D. R., Stansbie D. Familial pseudohyperkalaemia: inhibition of erythrocyte K+ efflux at 4 degrees C by quinine. Clin Sci (Lond) 1987 Nov;73(5):557–560. doi: 10.1042/cs0730557. [DOI] [PubMed] [Google Scholar]
  11. Karbwang J., Davis T. M., Looareesuwan S., Molunto P., Bunnag D., White N. J. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Br J Clin Pharmacol. 1993 Mar;35(3):265–271. [PMC free article] [PubMed] [Google Scholar]
  12. Kofi Ekue J. M., Phiri D. E., Mukunyandela M., Sheth U. K., Wernsdorfer W. H. Severe orthostatic hypotension during treatment of falciparum malaria. Br Med J (Clin Res Ed) 1988 Feb 6;296(6619):396–396. doi: 10.1136/bmj.296.6619.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mansor S. M., Molyneux M. E., Taylor T. E., Ward S. A., Wirima J. J., Edwards G. Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1-acid glycoprotein and the binding of quinine in Malawian children. Br J Clin Pharmacol. 1991 Sep;32(3):317–321. doi: 10.1111/j.1365-2125.1991.tb03905.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McGee S. R. Muscle cramps. Arch Intern Med. 1990 Mar;150(3):511–518. [PubMed] [Google Scholar]
  15. Mihaly G. W., Ching M. S., Klejn M. B., Paull J., Smallwood R. A. Differences in the binding of quinine and quinidine to plasma proteins. Br J Clin Pharmacol. 1987 Dec;24(6):769–774. doi: 10.1111/j.1365-2125.1987.tb03244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Okitolonda W., Delacollette C., Malengreau M., Henquin J. C. High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. Br Med J (Clin Res Ed) 1987 Sep 19;295(6600):716–718. doi: 10.1136/bmj.295.6600.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Okitolonda W., Pottier A. M., Henquin J. C. Glucose homeostasis in rats treated acutely and chronically with quinine. Eur J Pharmacol. 1986 Dec 16;132(2-3):179–185. doi: 10.1016/0014-2999(86)90603-5. [DOI] [PubMed] [Google Scholar]
  18. Oku J., Bray G. A., Fisler J. S. Effects of oral and parenteral quinine on rats with ventromedial hypothalamic knife-cut obesity. Metabolism. 1984 Jun;33(6):538–544. doi: 10.1016/0026-0495(84)90009-x. [DOI] [PubMed] [Google Scholar]
  19. Rauch K., Ray J., Graham G. Improved high-performance liquid chromatographic method for the determination of quinine in plasma. J Chromatogr. 1988 Aug 19;430(1):170–174. doi: 10.1016/s0378-4347(00)83148-5. [DOI] [PubMed] [Google Scholar]
  20. Reaven G. M. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary? Diabetes Care. 1984 May-Jun;7 (Suppl 1):17–24. [PubMed] [Google Scholar]
  21. Roche R. J., Silamut K., Pukrittayakamee S., Looareesuwan S., Molunto P., Boonamrung S., White N. J. Quinine induces reversible high-tone hearing loss. Br J Clin Pharmacol. 1990 Jun;29(6):780–782. doi: 10.1111/j.1365-2125.1990.tb03704.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Silamut K., White N. J., Looareesuwan S., Warrell D. A. Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg. 1985 Jul;34(4):681–686. doi: 10.4269/ajtmh.1985.34.681. [DOI] [PubMed] [Google Scholar]
  23. Stevens M. J., Edmonds M. E., Mathias C. J., Watkins P. J. Disabling postural hypotension complicating diabetic autonomic neuropathy. Diabet Med. 1991 Nov;8(9):870–874. doi: 10.1111/j.1464-5491.1991.tb02127.x. [DOI] [PubMed] [Google Scholar]
  24. Supanaranond W., Davis T. M., Pukrittayakamee S., Nagachinta B., White N. J. Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs. Eur J Clin Pharmacol. 1993;44(4):325–329. doi: 10.1007/BF00316467. [DOI] [PubMed] [Google Scholar]
  25. Supanaranond W., Davis T. M., Pukrittayakamee S., Silamut K., Karbwang J., Molunto P., Chanond L., White N. J. Disposition of oral quinine in acute falciparum malaria. Eur J Clin Pharmacol. 1991;40(1):49–52. doi: 10.1007/BF00315138. [DOI] [PubMed] [Google Scholar]
  26. Wanwimolruk S., Chalcroft S., Coville P. F., Campbell A. J. Pharmacokinetics of quinine in young and elderly subjects. Trans R Soc Trop Med Hyg. 1991 Nov-Dec;85(6):714–717. doi: 10.1016/0035-9203(91)90423-v. [DOI] [PubMed] [Google Scholar]
  27. Warburton A., Royston J. P., O'Neill C. J., Nicholson P. W., Jee R. D., Denham M. J., Dobbs S. M., Dobbs R. J. A quinine a day keeps the leg cramps away? Br J Clin Pharmacol. 1987 Apr;23(4):459–465. doi: 10.1111/j.1365-2125.1987.tb03076.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. White N. J., Chanthavanich P., Krishna S., Bunch C., Silamut K. Quinine disposition kinetics. Br J Clin Pharmacol. 1983 Oct;16(4):399–403. doi: 10.1111/j.1365-2125.1983.tb02184.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. White N. J., Looareesuwan S., Warrell D. A., Warrell M. J., Bunnag D., Harinasuta T. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria. Am J Med. 1982 Oct;73(4):564–572. doi: 10.1016/0002-9343(82)90337-0. [DOI] [PubMed] [Google Scholar]
  30. White N. J., Warrell D. A., Chanthavanich P., Looareesuwan S., Warrell M. J., Krishna S., Williamson D. H., Turner R. C. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med. 1983 Jul 14;309(2):61–66. doi: 10.1056/NEJM198307143090201. [DOI] [PubMed] [Google Scholar]
  31. Winstanley P., Newton C., Watkins W., Mberu E., Ward S., Warn P., Mwangi I., Waruiru C., Pasvol G., Warrell D. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration. Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):201–206. doi: 10.1016/0035-9203(93)90494-b. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES